// App-Quantinova.ai

: Characterisation of UK and US COPD populations in reference to exacerbation frequency and blood eosinophils level

Researchers

Presenter

  • Claus F. Vogelmeier

Principal Investigators

  • Konstantinos Kostikas

  • Juanzhi Fang

  • Bethan Jones

  • Christopher Morgan

  • Robert Fogel

  • Florian Gutzwiller

  • Hui Cao

Medical Centers

  • Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany,

  • Novartis AG, Basel, Switzerland

  • Novartis Pharmaceuticals Corporation East Hanover NJ United States

  • Pharmatelligence, Cardiff, United Kingdom,

Locations

  • Germany

  • Switzerland

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved